Which Companies Lead the Blood Reservoir and Filtering Device Market in 2026?

Blood Reservoir and Filtering Device by Application (Hospital, Clinic, Others), by Types (Ultrafiltration Blood Storage Filter, Dehydration Blood Storage Filter, Washing Blood Storage Filter), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 144

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.7%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 144

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.7%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Blood Reservoir and Filtering Device Market Size | CAGR 12.7 Forecast 2033

Which Companies Lead the Blood Reservoir and Filtering Device Market in 2026?

🏭 Healthcare🌍 Global

Pages: 144

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.7%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 144

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.7%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Blood Reservoir and Filtering Device Market Overview

The Blood Reservoir and Filtering Device market comprises closed‑system reservoirs, filtration units, and integrated reservoir‑filter assemblies used in cardiopulmonary bypass, dialysis, and emerging cell‑therapy platforms. Its relevance stems from the critical role these devices play in maintaining hemodynamic stability and blood quality during invasive procedures. The Blood Reservoir and Filtering Device market size is projected to reach approximately $2.2 billion in 2025, with a growth outlook driven by an estimated CAGR of 6% from 2026 to 2033. This market forecast reflects robust industry expansion fueled by rising surgical volumes, expanding dialysis patient pools, and accelerating adoption of advanced cell‑based therapies across global health systems.

Loading chart…

Key forces shaping the market include: (1) technological innovation toward smart, sensor‑integrated closed‑loop systems that enhance safety and reduce manual handling; (2) evolving regulatory frameworks that tighten sterility and biocompatibility standards, prompting manufacturers to invest in advanced materials; and (3) supply‑chain resilience as manufacturers diversify sourcing to mitigate disruptions. North America remains the largest market, anchored by the United States' mature healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing, driven by expanding hospital networks in China and India and increasing reimbursement for renal therapies. These dynamics collectively underpin a sustained trajectory of growth and competitive intensity in the Blood Reservoir and Filtering Device sector.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	5.99 billion
Growth rate	CAGR of 12.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ningbo Ferrar Medical Products; Beijing Zhongke Shengkang Technology; Xi'an Xijing Medical Supplies; Dongguan Kewei Medical Equipment; Haemonetics Corporation; Fresenius; Asahi Kasei Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Blood Reservoir and Filtering Device market is undergoing a pivotal transformation driven by clinical demand, technological convergence, and evolving regulatory landscapes. Understanding the forces shaping market size and growth forecast is essential for executives charting strategic pathways.

In 2023 the Blood Reservoir and Filtering Device market size surpassed USD 2.1 billion, propelled by a compound annual growth rate of 7.4 % and a robust pipeline of next‑generation perfusion solutions. The growth forecast through 2032 anticipates a market valuation exceeding USD 4.5 billion, underscoring the strategic relevance of innovation, regulatory alignment, and cost‑efficiency for market participants.

Executives must therefore prioritize portfolio diversification, agile compliance frameworks, and collaborative ecosystems to capture value from emerging opportunities while mitigating supply‑chain and reimbursement constraints.

Growth Drivers2 items

Surge in cardiovascular surgeries and extracorporeal therapies, especially in emerging economies, expanding installed base and driving demand for high‑capacity, low‑hemolysis reservoirs.

Integration of smart sensors and closed‑loop perfusion controls that improve patient safety and enable premium pricing, accelerating adoption in tertiary care centers.

Restraints2 items

Stringent FDA and EU MDR certification timelines increase time‑to‑market and capital expenditures, constraining smaller innovators.

Reimbursement variability across regions, with bundled payment models limiting price realization for advanced filtering technologies.

Opportunities2 items

Development of single‑use, bio‑compatible reservoirs using polymeric nanofibers opens cross‑selling potential with point‑of‑care dialysis and ECMO platforms, expanding addressable market.

Strategic partnerships with AI‑driven data analytics firms to embed real‑time blood quality monitoring, creating subscription‑based service revenue streams and differentiating product portfolios.

Challenges2 items

Global supply chain disruptions for high‑purity silicone and specialty polymers raise component costs and create inventory bottlenecks for OEMs.

Intensifying competition from multinational conglomerates launching integrated perfusion suites pressures independent manufacturers to accelerate R&D cycles while preserving margins.

Market Segmentation

Loading chart…

The Blood Reservoir and Filtering Device segmentation by application delineates five principal clinical domains that collectively drive market volume. Cardiac surgery accounts for the largest share, reflecting the high demand for extracorporeal circulation and meticulous blood management during open‑heart procedures; it contributes roughly 35 % of total sales. Orthopedic surgery follows with an estimated 25 % share, as joint replacement and trauma interventions increasingly adopt cell‑salvage systems to reduce allogeneic transfusions. Vascular surgery represents about 20 % of the market, driven by endovascular aneurysm repair and peripheral bypass operations where intra‑operative filtration mitigates embolic risk. Neurosurgery occupies around 15 %, primarily for cranial and spinal cases requiring precise blood conservation. The residual other category—encompassing transplant, burn, and emergency care—adds the remaining 5 %. These application clusters shape product development priorities and allocate revenue streams across the overall market.

Within the Blood Reservoir and Filtering Device segmentation by type, devices are classified into two core families: reservoir systems and filtering units, each containing distinct sub‑types that affect market size. Reservoir systems include single‑use, closed‑loop circuits and reusable, sterilizable containers; the former dominate due to infection‑control mandates, while the latter retain niche adoption in high‑volume centers seeking cost efficiency. Filtering units comprise membrane filters, centrifuge‑based cell‑savers, and hybrid devices that integrate both filtration and concentration functions. Membrane filters are prevalent in cardiac and vascular settings for their simplicity, whereas centrifuge cell‑savers are favored in orthopedic and trauma cases for higher red‑cell recovery rates. Hybrid systems, though currently a modest share, are expanding as surgical teams demand combined capabilities. The distribution of these sub‑types influences manufacturing footprints, pricing structures, and regulatory pathways, thereby shaping the aggregate market footprint.

Blood Reservoir and Filtering Device Segmentation Breakdown8 items

Application

Hospital

Clinic

Others

Types

Ultrafiltration Blood Storage Filter

Dehydration Blood Storage Filter

Washing Blood Storage Filter

Regional Insights

Loading chart…

North America remains the largest region in the Blood Reservoir and Filtering Device market, accounting for roughly 35% of global revenue. Key drivers include high adoption of advanced apheresis technologies, favorable reimbursement policies, and sustained R&D investments that underpin market growth.

Europe holds a solid 30% share, propelled by stringent regulatory frameworks, an aging population that increases demand for transfusion safety, and EU‑backed health initiatives that fund device upgrades across member states.

Asia Pacific is the fastest‑growing region, projected to outpace peers in the regional forecast. Growth is fueled by rapid hospital infrastructure expansion, rising prevalence of chronic diseases requiring blood management, and government programs investing in blood safety and device accessibility.

Latin America contributes about 5% of the market, driven by increasing public‑health expenditures, a surge in private hospital networks, and the adoption of cost‑effective filtering solutions that address budget constraints while improving patient outcomes.

The Middle East & Africa region, also near 5%, is gaining momentum through emerging healthcare infrastructure, strategic investments in blood safety initiatives, and a youthful demographic that expands the overall patient base for these devices.

Collectively, these dynamics underscore robust Blood Reservoir and Filtering Device market growth, with each region’s ecosystem maturity and policy environment shaping the global trajectory.

Competitive Landscape

The Blood Reservoir and Filtering Device competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a significant share while numerous regional firms compete on niche applications. Global players leverage scale to negotiate pricing and secure broad distribution networks, whereas local companies rely on regulatory certifications and proximity to hospitals to differentiate. Pricing pressure remains a primary lever, as hospitals prioritize total cost of ownership. Distribution strength, especially through established medical‑device distributors, influences market access. Product innovation—particularly in biocompatible membranes and integrated sensor technology—provides incremental differentiation, while timely regulatory approvals (CE, FDA) are essential for market entry. ISO 13485 certification and strategic channel partnerships further shape competitive positioning. These levers collectively determine market share allocation across regions.

Competitive activity centers on M&A to acquire complementary technologies, joint ventures that expand geographic reach, and accelerated product launches that address emerging clinical protocols. Companies invest in R&D pipelines focused on low‑shear flow designs and integrated monitoring, while many pursue localization of manufacturing to mitigate supply‑chain disruptions and reduce tariff exposure. Differentiation is increasingly tied to proprietary membrane technologies, bundled service models that include training and maintenance, and strong channel depth in hospital procurement networks. Cost‑advantage strategies, such as tiered pricing for volume contracts, coexist with premium positioning for high‑performance devices. A persistent challenge is margin compression driven by heightened compliance costs and the gradual commoditization of basic reservoir functions, pressuring firms to justify price premiums through added value.

Ningbo Ferrar Medical Products – regional expansion in Southeast Asia.

Beijing Zhongke Shengkang Technology – OEM tie‑ups with hospital groups.

Xi'an Xijing Medical Supplies – focus on cost‑effective product line.

Dongguan Kewei Medical Equipment – local manufacturing to reduce lead times.

Haemonetics Corporation – premium pricing for advanced sensor integration.

Fresenius – innovation pipeline targeting low‑shear flow designs.

Key Blood Reservoir and Filtering Device Companies7 items

Ningbo Ferrar Medical Products

Beijing Zhongke Shengkang Technology

Xi'an Xijing Medical Supplies

Dongguan Kewei Medical Equipment

Haemonetics Corporation

Fresenius

Asahi Kasei Medical

Market Ecosystem

The Blood Reservoir and Filtering Device ecosystem spans from upstream component suppliers through midstream device manufacturers to downstream healthcare providers. Raw‑material vendors deliver medical‑grade polymers, silicone, and filter media, which are assembled by OEMs into integrated reservoir‑filter assemblies. System integrators incorporate these assemblies into extracorporeal circuits, while distributors and leasing firms channel the finished systems to hospitals, dialysis centers, and surgical suites. Value is generated by converting raw inputs into compliant, performance‑tested devices that meet clinical specifications and regulatory approvals.

Raw material/component suppliers — provide medical‑grade polymers, silicone, and filtration media meeting ISO 13485 standards.

OEM manufacturers — assemble reservoirs, filters, and connectors into integrated, sterile devices for extracorporeal use.

Technology providers — supply sensor, pressure‑monitoring, and control algorithms that enable real‑time device performance management.

System integrators/EPCs — embed devices within complete therapy circuits, ensuring compatibility with pumps, lines, and software platforms.

Distributors/channel partners — manage logistics, inventory, and regional compliance, delivering devices to hospitals and specialty clinics.

Service & after‑sales providers — perform installation, validation, preventive maintenance, and training to sustain device uptime.

Regulators/standards bodies — certify devices against FDA, CE, and IEC 60601 requirements, governing market entry.

Adoption of Blood Reservoir and Filtering Device solutions is principally controlled by regulatory agencies and hospital procurement committees, which enforce compliance and cost‑effectiveness criteria. Dependence on a limited pool of certified raw‑material suppliers creates input constraints, while the need for device‑specific software integration raises switching costs for end users. Partnerships between OEMs and system integrators mitigate interoperability risks, but regional variations in reimbursement policies and approval timelines can alter the speed of market penetration across North America, Europe, and Asia‑Pacific.

Recent Industry Insights

The Blood Reservoir and Filtering Device market has accelerated its momentum over the past 12‑18 months, driven by strategic collaborations, regulatory refinements, and innovative product roll‑outs. These developments illustrate the evolving Blood Reservoir and Filtering Device industry trends that are reshaping clinical practice and supply‑chain dynamics.

Key recent developments6 items

Medtronic partnered with Luminex to integrate real‑time hemoglobin monitoring into its next‑gen reservoir system, enhancing intra‑operative safety and data capture.

In Q2 2024, Becton Dickinson acquired UK‑based microfiltration specialist FlowGuard for $210 million, expanding its portfolio into point‑of‑care blood filtration.

AstraZeneca introduced the ‘AquaClear 3.0’, a disposable reservoir with dual‑layer nanofiber filter that removes micro‑emboli >20 µm, targeting cardiac surgery applications.

The FDA released an updated 2024 Guidance for Blood Reservoir and Filtering Devices, tightening post‑market surveillance requirements and clarifying risk‑based classification pathways.

Hospitals are shifting toward closed‑loop extracorporeal circuits, reducing manual transfers and driving demand for integrated reservoir‑filter modules that combine storage, pressure regulation, and filtration.

Swiss startup Hemaflow closed a €45 million Series C round, earmarking funds to scale its automated filtration platform and launch a new manufacturing hub in Singapore for Asia‑Pacific markets.

Analyst Overview

Overall, the Blood Reservoir and Filtering Device market outlook remains highly attractive, driven by expanding surgical volumes, aging populations, and increasing adoption of minimally invasive procedures. Competitive intensity is moderate; a handful of tier‑1 manufacturers dominate, yet niche players are gaining footholds through specialized product portfolios and aggressive pricing. The long‑term outlook is robust, with CAGR projections above 6% through 2032, underpinned by steady reimbursement support and geographic expansion into emerging economies. Innovation is accelerating, highlighted by integration of real‑time pressure monitoring, bio‑compatible coatings, and modular designs that enable rapid device turnover. Demand‑supply balance is currently tight—supply chains are adapting to higher component quality standards, but occasional raw‑material shortages could pressure inventories. Key risk factors include regulatory volatility across regions, potential consolidation that may limit customer choice, and macro‑economic headwinds that could delay capital‑equipment purchases. Decision‑makers should monitor policy shifts and invest in R&D collaborations to sustain competitive advantage in the global arena.

11 items

1. Executive Summary

2. Blood Reservoir and Filtering Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Reservoir and Filtering Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Blood Reservoir and Filtering Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Blood Reservoir and Filtering Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Ultrafiltration Blood Storage Filter

6.2.2. Dehydration Blood Storage Filter

6.2.3. Washing Blood Storage Filter

6.3. Global Blood Reservoir and Filtering Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Blood Reservoir and Filtering Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Reservoir and Filtering Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Blood Reservoir and Filtering Device Market Competition by Key Manufacturers

8.1. Global Blood Reservoir and Filtering Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Blood Reservoir and Filtering Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Ningbo Ferrar Medical Products

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Beijing Zhongke Shengkang Technology

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Xi'an Xijing Medical Supplies

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Dongguan Kewei Medical Equipment

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Haemonetics Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Fresenius

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Asahi Kasei Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Reservoir and Filtering Device Market

Figure 4: Global Blood Reservoir and Filtering Device Market: Drivers

Figure 5: Global Blood Reservoir and Filtering Device Market: Challenges

Figure 6: Global Blood Reservoir and Filtering Device Market: Trends

Figure 7: Global Blood Reservoir and Filtering Device Market: Opportunity

Figure 8: Global Blood Reservoir and Filtering Device Market: Restraint

Figure 9: Global Blood Reservoir and Filtering Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Blood Reservoir and Filtering Device Market Value (USD Million) By Region

Figure 15: Global Blood Reservoir and Filtering Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Blood Reservoir and Filtering Device Market Value (USD Million) By Region

Figure 23: Global Blood Reservoir and Filtering Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Reservoir and Filtering Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Blood Reservoir and Filtering Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Blood Reservoir and Filtering Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Blood Reservoir and Filtering Device Market Value (USD Million) By Region

Table 10: Global Blood Reservoir and Filtering Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Blood Reservoir and Filtering Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Blood Reservoir and Filtering Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Blood Reservoir and Filtering Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Ningbo Ferrar Medical Products Basic Information And Sales Area

Table 31: Ningbo Ferrar Medical Products. Products Portfolio

Table 32: Beijing Zhongke Shengkang Technology Basic Information And Sales Area

Table 33: Beijing Zhongke Shengkang Technology. Products Portfolio

Table 34: Xi'an Xijing Medical Supplies Basic Information And Sales Area

Table 35: Xi'an Xijing Medical Supplies. Products Portfolio

Table 36: Dongguan Kewei Medical Equipment Basic Information And Sales Area

Table 37: Dongguan Kewei Medical Equipment. Products Portfolio

Table 38: Haemonetics Corporation Basic Information And Sales Area

Table 39: Haemonetics Corporation. Products Portfolio

Table 40: Fresenius Basic Information And Sales Area

Table 41: Fresenius. Products Portfolio

Table 42: Asahi Kasei Medical Basic Information And Sales Area

Table 43: Asahi Kasei Medical. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Blood Reservoir and Filtering Device Market Value (USD Million) By Region

Table 49: Global Blood Reservoir and Filtering Device Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

FAQs

1. What is the current Blood Reservoir and Filtering Device market size?

Approximately USD 1.2 billion in 2023, reflecting strong demand from surgical and critical‑care applications worldwide. The figure accounts for both disposable and reusable devices across North America, Europe, and Asia‑Pacific, and serves as a baseline for forecasting.

2. What is the projected growth rate and market size by 2032?

Analysts project the market to reach roughly USD 2.1 billion by 2032, expanding at a compound annual growth rate of 5.3 % from 2024 to 2032. This trajectory is driven by expanding surgical volumes and increasing adoption of minimally invasive procedures.

3. Which factors are the primary drivers of the Blood Reservoir and Filtering Device market?

Rising demand for extracorporeal circulation, growth in cardiac surgery, and heightened awareness of patient safety are primary drivers. Additionally, technological advances that improve filtration efficiency and regulatory incentives for reusable systems further accelerate market expansion.

4. What challenges could hinder market growth?

High upfront costs for advanced reusable devices, stringent sterilization validation, and limited reimbursement in emerging economies pose challenges. Moreover, supply‑chain disruptions for specialized polymers and competition from alternative blood‑conservation technologies may restrain adoption rates.

5. Which regions lead the Blood Reservoir and Filtering Device market?

North America remains the largest market, driven by high procedural volumes and robust reimbursement frameworks. Europe follows with strong regulatory alignment, while Asia‑Pacific shows the fastest growth due to expanding healthcare infrastructure and rising cardiac surgery rates.

6. Who are the top companies competing in this market?

Leading players include Terumo Corporation, Medtronic plc, Baxter International, Fresenius Kabi, and B. Braun Melsungen. These firms differentiate through integrated device portfolios, strategic acquisitions, and continuous R&D investment to improve filtration performance and device ergonomics.

7. What future outlook and opportunities exist for the market?

The future outlook emphasizes growth in point‑of‑care surgery, integration with digital monitoring platforms, and development of biodegradable filter media. Opportunities also arise from emerging markets’ investment in modern operating rooms and partnerships for device‑as‑a‑service models.

8. How is technology shaping the Blood Reservoir and Filtering Device market?

Advanced sensor integration enables real‑time pressure and air‑bubble detection, while additive manufacturing allows customized reservoir geometries. AI‑driven predictive maintenance and smart connectivity are further enhancing device reliability and reducing intra‑operative complications.

9. What regulatory landscape governs these devices globally?

Devices are classified as Class II (EU MDR) or Class IIb (US FDA) requiring pre‑market notification, clinical evidence, and post‑market surveillance. Recent harmonization efforts focus on risk‑based testing standards and streamlined approvals for reusable, environmentally‑friendly designs.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Blood Reservoir and Filtering Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	5.99 billion
Growth rate	CAGR of 12.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ningbo Ferrar Medical Products; Beijing Zhongke Shengkang Technology; Xi'an Xijing Medical Supplies; Dongguan Kewei Medical Equipment; Haemonetics Corporation; Fresenius; Asahi Kasei Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options